#gastriccancer — Public Fediverse posts

Rice, fish and pickles: Is the traditional Japanese diet as healthy as we think?

From fish and seaweed to miso soup and pickles, researchers examine how the foods that define traditional Japanese…
#EuropeSays #Japan #JP #cancer #Diet #disability #fish #Food #GastricCancer #greentea #Japanese #MediterraneanDiet #Mortality #nutrition #Research #Sarcopenia #Soy #tea #vegetables
https://www.europesays.com/japan/109817/

AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug deal

AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug deal Proactive uses images sourced from Shutterstock AstraZeneca…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bispecificantibody #Cancer #cancerdrug #commercialrights #gastriccancer #Lungcancer #SummitTherapeutics #SummitTherapeuticsInc.
https://www.europesays.com/britain/137957/

https://www.europesays.com/britain/137957/ AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug deal #AstraZeneca #BispecificAntibody #Cancer #CancerDrug #CommercialRights #GastricCancer #LungCancer #SummitTherapeutics #SummitTherapeuticsInc

Advances in gastric cancer management reviewed.

🌍 Global health concern: 7.7% of cancer deaths
🎯 Early detection vital for prognosis
🧬 Molecular profiling offers hope
🧪 Trials boost therapy strategies

#GastricCancer #Oncology #GlobalHealth

https://tnyp.me/mkzMBbpw/m

Review: Advances in Gastric Cancer Management

🧪 Gastric cancer ranks as the 5th most common malignancy.
📉 Survival rate is 36.4%; early detection crucial.
📊 Asian Americans have better outcomes due to genetics.

https://tnyp.me/mkzMBbpw/m #CancerResearch #GastricCancer #Oncology

Advancements in gastric cancer management:

🧪 Multimodality treatments improve survival
🔬 7.7% of global cancer deaths
📊 Early detection crucial: 33.7% diagnosed metastatic
🔍 Genetic profiling, immunotherapy emergent

#GastricCancer #Oncology #PrecisionMedicine

https://tnyp.me/mkzMBbpw/m

https://www.europesays.com/ie/653862/ Study confirms benefits of robotic gastric cancer surgery #blood #cancer #education #Éire #Gastrectomy #GastricCancer #Health #hospital #IE #Ireland #LaparoscopicSurgery #Q #Research #Students #Surgery #Technology

A decades-long study raises questions about sugary drinks and stomach cancer

Tracking decades of beverage habits in two major U.S. cohorts, researchers investigated whether what people drink could help…
#NewsBeep #News #Health #Alcohol #AU #Australia #Cancer #Colorectal #Fish #Fructose #GastricCancer #Helicobacterpylori #Liver #mortality #research #Stomach #stomachcancer #Tobacco #Vegetables
https://www.newsbeep.com/au/861572/

Special journal issue highlights precision prevention in cancer epidemiology

Cancer epidemiology is not merely about counting cases; it is a dynamic field that infor…
#NewsBeep #News #Health #AU #Australia #BreastCancer #Cancer #clinicaltrial #Colorectal #ColorectalCancer #diet #epidemiology #GastricCancer #Genetic #Healthcare #Helicobacterpylori #HelicobacterpyloriInfection #lungcancer #medicine #Mentalhealth #mortality #OvarianCancer #publichealth #research
https://www.newsbeep.com/au/861305/

https://www.europesays.com/ie/624702/ Autophagy modulation emerges as a strategy against cisplatin-resistant gastric cancer #Autophagy #cancer #Cell #CellBiology #CellDeath #chemotherapy #Cisplatin #DNA #Éire #GastricCancer #Gene #Genes #Health #IE #Ireland #medicine #Tumor

AstraZeneca reports Phase III results for Ultomiris and Sone-Ve

AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
#EuropeSays #Britain #Europe #EU #AstraZeneca #gastriccancer #HSCT-TMA #OrphanDrugDesignation #paediatricpatients #PhaseIII #PhaseIIItrial #primaryendpoint #statisticalsignificance #thromboticmicroangiopathy #Ultomiris
https://www.europesays.com/britain/92171/

https://www.europesays.com/britain/92171/ AstraZeneca reports Phase III results for Ultomiris and Sone-Ve #AstraZeneca #GastricCancer #HSCTTMA #OrphanDrugDesignation #PaediatricPatients #PhaseIII #PhaseIIITrial #PrimaryEndpoint #StatisticalSignificance #ThromboticMicroangiopathy #Ultomiris

AstraZeneca reports Phase III results for Ultomiris and Sone-Ve

AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
#EuropeSays #Britain #Europe #EU #AstraZeneca #gastriccancer #HSCT-TMA #OrphanDrugDesignation #paediatricpatients #PhaseIII #PhaseIIItrial #primaryendpoint #statisticalsignificance #thromboticmicroangiopathy #Ultomiris
https://www.europesays.com/britain/92116/

https://www.europesays.com/britain/92116/ AstraZeneca reports Phase III results for Ultomiris and Sone-Ve #AstraZeneca #GastricCancer #HSCTTMA #OrphanDrugDesignation #PaediatricPatients #PhaseIII #PhaseIIITrial #PrimaryEndpoint #StatisticalSignificance #ThromboticMicroangiopathy #Ultomiris

AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat

July 27 (Reuters) – AstraZeneca backed its annual and long-term forecasts on Monday after topping second-quarter profit expectations…
#EuropeSays #Britain #Europe #EU #AstraZeneca #drugpipeline #gastriccancer #PascalSoriot #raredisease
https://www.europesays.com/britain/91773/

https://www.europesays.com/britain/91773/ AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat #AstraZeneca #DrugPipeline #GastricCancer #PascalSoriot #RareDisease

AstraZeneca reports Sone-Ve boosts gastric cancer survival | AZN SEC Filing

FORM 6-K   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Report of Foreign Issuer   Pursuant…
#EuropeSays #Britain #Europe #EU #AstraZeneca #antibodydrugconjugate #AZN #BreakthroughDesignation #CLARITY-Gastric01 #CLDN18.2 #gastriccancer #OrphanDrugDesignation #overallsurvival #Sone-Ve
https://www.europesays.com/britain/91636/

https://www.europesays.com/britain/91636/ AstraZeneca reports Sone-Ve boosts gastric cancer survival | AZN SEC Filing #AntibodyDrugConjugate #AstraZeneca #AZN #BreakthroughDesignation #CLARITYGastric01 #CLDN182 #GastricCancer #OrphanDrugDesignation #OverallSurvival #SoneVe

https://www.europesays.com/ch/107390/ Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum #BloodCancer #BreastCancer #CER #CHF #GastricCancer #GlobalGrowth #LungCancer #Roche #RocheHoldingAG #ZacksInvestmentResearch

https://www.europesays.com/ch/107364/ Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum #BloodCancer #BreastCancer #CER #CHF #GastricCancer #GlobalGrowth #LungCancer #Roche #RocheHoldingAG #ZacksInvestmentResearch

https://www.europesays.com/ie/539189/ New biomarker predicts gastric cancer outcomes from CT scans #Adipose #Biomarker #cancer #CancerTreatment #ComputedTomography #CT #education #Éire #GastricCancer #Health #IE #Ireland #Muscle #Nutrition #oncology #radiology #Research #Tomography #Tumor

https://www.europesays.com/ie/457840/ Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers #Éire #GastricCancer #Health #IE #Ireland #LiverCancer #LungCancer #PancreaticCancer #ProstateCancer #RadiationTherapy #Radionuclide #TreatmentResistantTumor #Xofigo

https://www.europesays.com/ch/55699/ RHHBY’s Q1 Results Hit by Currency Headwinds, Sales Up 6% at CER #BloodCancer #BreastCancer #CER #CHF #GastricCancer #Roche #RocheHoldingAG #ZacksInvestmentResearch

#Cancer prevention has been broadly linked to plant-based #diets. Now a new study found that greater adherence to healthy #plantbased diets was also linked lower risk of #GastricCancer, suggesting that higher-quality plant-based diets may help prevent gastric cancer: doi.org/10.1002/fsn3... #health

Plant‐Based Diet Quality and G...

#Cancer prevention has been broadly linked to plant-based #diets. Now a new study found that greater adherence to healthy #plantbased diets was also linked lower risk of #GastricCancer, suggesting that higher-quality plant-based diets may help prevent gastric cancer: doi.org/10.1002/fsn3... #health

Plant‐Based Diet Quality and G...

https://www.europesays.com/ie/422795/ Study finds increasing rates of therapy-related acute myeloid leukemia #AcuteMyeloidLeukemia #blood #Bone #BoneMarrow #BreastCancer #cancer #CancerTherapy #CancerTreatment #chemotherapy #DNA #DNADamage #Éire #GastricCancer #Health #IE #Ireland #Leukemia #MyeloidLeukemia #therapy

https://www.europesays.com/ie/406230/ Study explores racial differences in gastric cancer immunotherapy outcomes #cancer #chemotherapy #Éire #GastricCancer #Health #hospital #IE #immunity #immunotherapy #Ireland #medicine #Microbiome #PDL1 #Research #Tumor

https://www.europesays.com/ch/34628/ RHHBY’s Sales Up 7% in First 9 Months of 2025, ’25 Earnings View Raised #BloodCancer #BreastCancer #CER #CHF #GastricCancer #LungCancer #Roche #RocheHoldingAG #ZacksInvestmentResearch

https://www.europesays.com/ie/346270/ The Role of the Gut Microbiome in Gastrointestinal Cancer Development #CancerBiology #ColorectalCancer #Éire #GastricCancer #GastrointestinalCancer #Gut #Health #IE #Ireland #MicrobialMetabolites #Microbiome #PrecisionOncology #TumorMicroenvironment

https://www.europesays.com/uk/737175/ AstraZeneca’s Imfinzi Perioperative Regimen Secures Key Backing in EU; Shares to Begin Trading in New York #AstraZeneca #BritishPharmaceutical #DocetaxelChemotherapy #EU #Europe #European #EuropeanMedicinesAgency #EuropeanUnion #GastricCancer #GastroesophagealJunction #Imfinzi #NewYork #NewYorkStockExchange

Genetic Testing in Familial Gastric Cancer Genetic testing + H. pylori evaluation helps refine risk in those with a family history of gastric cancer.

Key genes: CDH1, CTNNA1, BRCA1/2, PALB2, MLH1, MSH2.

Early-onset (<40 yrs) & syndromic cases (HDGC, Lynch) warrant testing.

#GastroAGI #GastricCancer #Genetics

GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer

Collaboration builds clinical foundation…
#Japan #JP #Hokkaido #biotechnologycompany #clinicaldevelopment #clinicalstage #gastriccancer #GlycoNex #HokkaidoNews #hokkaidouniversity #Inc. #news #treatmentoption #treatmentoptions #北海道
https://www.alojapan.com/1418105/glyconex-and-hokkaido-university-hospital-launch-study-to-advance-glycan-directed-adc-development-in-gastric-cancer-2/

https://www.alojapan.com/1418105/glyconex-and-hokkaido-university-hospital-launch-study-to-advance-glycan-directed-adc-development-in-gastric-cancer-2/ GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer #BiotechnologyCompany #ClinicalDevelopment #ClinicalStage #GastricCancer #GlycoNex #Hokkaido #HokkaidoNews #HokkaidoUniversity #Inc. #Japan #news #TreatmentOption #TreatmentOptions #北海道 Collaboration builds clinical foundation for GNX1021, a first-in-class glycan-directed ADC being developed for gastric cancer patients  NEW TAIP

Spatiotemporal analysis of gastric cancer incidence in Iran from 2014 to 2018: a geospatial epidemiological study | BMC Public Health https://www.byteseu.com/1510619/ #Biostatistics #CancerEpidemiology #Conflicts #EnvironmentalHealth #epidemiology #GastricCancer #General #GeographicInformationSystems #Iran #Medicine/PublicHealth #PublicHealth #SpatialAnalysis #vaccine

https://www.europesays.com/2544746/ Spatiotemporal analysis of gastric cancer incidence in Iran from 2014 to 2018: a geospatial epidemiological study | BMC Public Health #Biostatistics #CancerEpidemiology #Conflicts #EnvironmentalHealth #Epidemiology #GastricCancer #general #GeographicInformationSystems #Iran #Medicine/PublicHealth #PublicHealth #SpatialAnalysis #Vaccine

Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology. https://doi.org/10.3389/fphar.2024.1373007 #GastricCancer #PrecisionOncology #EthnicGroups #GenomicAlterations #TherapeuticStrategies

Novartis further entrenches into radiopharma with $1B Mariana buy—Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 —Merck reports data from Phase III gastric cancer treatment trial --http://bit.ly/w28kSd #earnings #novartis #radiopharmaceuticals #mergersandacquisitions #novonordisk #ozempic #wegovy #merck #clinicaltrials #gastriccancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Join us @prereview & the Journal of Medical Internet Research (JMIR) in a virtual Live Review to provide constructive feedback to the #preprint “Assessing the Incidence of Postoperative Diabetes in Gastric Cancer Patients: A Comparative Study of Roux-en-Y Gastrectomy and Other Surgical Reconstruction Techniques” - by Tatsuki Onishi medRxiv: https://doi.org/10.1101/2024.01.13.24301276

Register: http://bit.ly/Live-Review-Apr-19-24

#T2DM #GastricCancer #GutMicrobiota #OpenScience #AcademicCommunity #PeerReview #Anesthesia

GSK buying Aiolos for $1.4B to boost asthma pipeline —Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals— FDA declines to approve Astellas' gastric cancer drug --http://bit.ly/w28kSd #gsk #asthma #mergersandacquisitions #bristolmyerssquibb #fda #gastriccancer #astellas #jpmhc24 #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Merck expands Keytruda's label as a first-line option for gastric cancer -- Novo Nordisk offers staff free Wegovy --Top FDA official Woodcock to retire early next year-- See more on our front page news http://bit.ly/w28kSd #merck #keytruda #gastriccancer #novonordisk #wegovy #fda #janetwoodcock #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

BMS signs ADC development deal with Munich-based biotech worth more than $1B —BeiGene's gastric cancer drug succeeds in late-stage trial— FDA green lights Roche's Polivy in first-line DLBCL-- See more on our front page news http://bit.ly/w28kSd #bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

*From #TumorBoardTuesday archives*

📖Thinking biomarkers but moving to use in #GastricCancer Take a look at @KlempnerSam's October 2021 case presentation & wrap up.

Is there something you'd do different with any updates?
@MPishvaian @JohnEbbenMDPhD

---
RT @TumorBoardTues
1/10 #TumorBoardTuesday
Thursday Case🎀
This week’s case: pt w #GEA not responding to FLOT w dMMR/MSI. Receives 3 doses of pembrolizumab->pCR!

💡Biomarker-based I…
https://twitter.com/TumorBoardTues/status/1453930644094865414

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort — AbbVie leaves PhRMA, BIO: reports —Astellas’ Phase III gastric cancer therapy trial meets primary endpoint -- See more on our front page news http://bit.ly/w28kSd #astrazeneca #patents #Symbicort #BIO #PhRMA #abbvie #astellas #clinicaltrials #gastriccancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

#TumorBoardTuesday

🔬🧬We had a discussion on a new target, Claudin 18.2 in #GastricCancer & #GEJ cancers led by @KlempnerSam

➡️Here’s the Thursday Case 🎀

👉 🆓CME: answer 3 quick ❓
ALL CME 🔗: http://integrityce.com/tbt
CME eval🔗: http://integrityce.com/tbteval

📢We’re here for #TumorBoardTuesday!!

🥼@KlempnerSam knocks down some pending Q’s about Claudin 18.2 (CLDN 18.2) for upper GI cancer #GastricCancer

👇🏽👇🏽

📱Weigh in your answer
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👨🏼‍⚕️tag peers
@MPishvaian @JohnEbbenMDPhD
#MedTwitter
---
RT @KlempnerSam
@TumorBoardTues 1/15 #TumorBoardTuesday #GastricCancer #OncTwitter
Here goes

🎬Starting out with an overall poll Q

When a new advanced GC/GEJ pa…
https://twitter.com/KlempnerSam/status/1600294104872542209

⏳1 hour until TONIGHT'S #TumorBoardTuesday!!⏳

🪵@KlempnerSam brings us 🔥NEW🔥 developments & approaches to clinical convos in Claudin 18.2 for #GastricCancer

🪵Grease up the chains & prepare your fingers with these 3 #CME👇🏽

🪵See you soon!

---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest❓Free #CME🔗: http://integrityce.com/tbt

🤔B4⃣ @KlempnerSam🗣️Claudin 18.2🎯💊in upper GI Ca, test your🧠with these 3 Q's:

What did the addition of …
https://twitter.com/TumorBoardTues/status/1600108816959315968

🪵There’s been developments in testing & treating #GastricCancer/GEJ!!

🪓Join #TumorBoardTuesday on 12/06/22 at 8pm ET when @KlempnerSam takes us through potential approaches to clinical convos between patients & clinicians regarding claudin 18.2

🪵Prepare your own Q’s NOW

Set a ⏲ to join #TumorBoardTuesday on 12.06.22 at 8pm ET

📅Tues 12.06.22 at 8pm ET
👨🏻‍⚕️@KlempnerSam
📰Claudin 18.2 & new developments!!

🪵While we finalize the case, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼#OncTwitter #GastricCancer